Table 4. Chemotherapy protocol and outcome at re-evaluation.
Chemotherapy protocol and outcome | n | % |
---|---|---|
GP | 40 | 23.5 |
PE | 39 | 22.9 |
PC | 58 | 34.1 |
Other | 33 | 19.4 |
Antibiotic | 12 | 8.3 |
Disease control at re-evaluation | 84 | 59.6 |
IQR, interquartile range; GP, gemcitabine-cisplatin; PE, cisplatin-etoposide; PC, paclitaxel-carboplatin.